HIV doulas: a new way to support moms and babies?
NCT ID NCT07664423
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a doula support program for 15 pregnant women with HIV in South Florida. The doula will provide education, adherence support, and lactation counseling from pregnancy through 12 weeks after birth. The goal is to see if this program is feasible and acceptable, and to improve health outcomes for mothers and babies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Doula support intervention (behavioral support including education, adherence support, and lactation counseling)
What this could lead to
If successful, this program could provide a model for supporting pregnant women with HIV in making informed infant feeding choices and improving maternal and child health.
What could go wrong
This is a very small early feasibility study with only 15 participants, so results may not apply broadly. The program may not be acceptable or feasible in other settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami School of Medicine
Miami, Florida, 33136, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••